Patients are being warned of an urgent recall over a common blood pressure drugs over fears it contains chemicals that can cause cancer.
The Medicines and Healthcare products Regulatory Agency (MHRA) issued a notice concerning 25 batches of Irbesartan-containing medicinal products.
The recall is due to “contamination with an impurity that could potentially increase the risk of cancer over time”.
While there is no proof that the batches has posed any health concerns to patients, the MHRA said it is taking “precautionary” measures to limit the risk of the chemical impurity.
The recall has only been issued to pharmacies and wholesalers so patients do not need to check their own medication.
Patients have been warned that not taking high blood pressure medication could lead to further ill health, with experts urging people to speak to their GP before abruptly stopping taking their medication.
‘Continue to take your medication’
Dr Alison Cave, MHRA chief safety officer, said: “Patient safety is at the heart of what we do.
“We’re recalling batches of certain sartan-containing products as a precautionary measure while we continue our investigation.
“If you’ve been taking one of the affected products, continue to take your medication.
Previous recalls of these types of products in 2018, 2019 and June 2021 are part of an ongoing investigation.
“The MHRA is working with other medicines regulators on
Comments & Moderation
Readers’ comments: You are personally liable for the content of any comments you upload to this website, so please act responsibly. We do not pre-moderate or monitor readers’ comments appearing on our websites, but we do post-moderate in response to complaints we receive or otherwise when a potential problem comes to our attention. You can make a complaint by using the ‘report this post’ link . We may then apply our discretion under the user terms to amend or delete comments.
Post moderation is undertaken full-time 9am-6pm on weekdays, and on a part-time basis outwith those hours.
Read the rules hereComments are closed on this article